Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Delta variant already dominant in U.S., CDC estimates show

Published 07/07/2021, 11:13 AM
Updated 07/07/2021, 12:35 PM
© Reuters. FILE PHOTO: A man receives a coronavirus disease (COVID-19) test at a mobile testing van in Brooklyn, New York, U.S., June 2, 2021. REUTERS/Brendan McDermid
PFE
-
AZN
-
MRNA
-

By Mrinalika Roy

(Reuters) - The Delta variant is already the dominant strain of COVID-19 in the United States, according to data modeling done by the U.S. Centers for Disease Control and Prevention (CDC).

According to the health agency's estimates the Delta variant became dominant in the country over the two weeks ended July 3, with 51.7% cases linked to the variant that was first identified in India.

The proportion of cases linked to the Alpha variant which was first identified in Britain and had been dominant in the United States so far, fell to 28.7%.

The data, which shows the estimated biweekly proportions of the most common SARS-CoV-2 lineages circulating in the United States, is based on sequences collected through CDC's national genomic surveillance since Dec. 20, 2020.

The Delta variant, which is becoming dominant in many countries, is more easily transmitted than earlier versions of the coronavirus and may cause more severe disease, especially among younger people. It has now been found in every U.S. state, health officials have said.

© Reuters. FILE PHOTO: A man receives a coronavirus disease (COVID-19) test at a mobile testing van in Brooklyn, New York, U.S., June 2, 2021. REUTERS/Brendan McDermid

On Tuesday, U.S. President Joe Biden encouraged Americans who have not yet been vaccinated against COVID-19 to get their shots to protect themselves from the widely spreading, highly contagious variant.

So far, preliminary data has shown that vaccines made by Pfizer Inc (NYSE:PFE) and BioNTech, AstraZeneca (NASDAQ:AZN) and Moderna (NASDAQ:MRNA) are largely protective against Delta, with the concentration of virus-neutralizing antibodies being somewhat reduced.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.